neuropsychiatric

DDN Webinar: Tripping the Neuropsychiatric

Psychedelics like psilocybin, DMT, and LSD are increasingly welcomed in behavioural and psychiatric research, with implications that extend well beyond neuroscience. This webinar will delve into efforts to transform anecdotal evidence into supported medical interventions through systematic research and controlled clinical trials.
Subscribe to Newsletter
Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

September 2024 front cover

Latest Issue  

• Volume 20 • Issue 5 • September 2024

September 2024

September 2024 Issue